» Articles » PMID: 32628368

Opioid Use Disorder Treatment and Potential Interactions With Novel COVID-19 Medications: A Clinical Perspective

Overview
Date 2020 Jul 7
PMID 32628368
Citations 5
Authors
Affiliations
Soon will be listed here.
Citing Articles

The Association of Opioid Use Disorder and COVID-19, a Longitudinal Study.

Jamali Z, Emamian M, Hashemi H, Fotouhi A Int J Prev Med. 2023; 13:157.

PMID: 36910999 PMC: 9999101. DOI: 10.4103/ijpvm.ijpvm_68_22.


Risk of COVID-19 infection and the associated hospitalization, ICU admission and mortality in opioid use disorder: a systematic review and meta-analysis.

Behnoush A, Bazmi E, Forouzesh M, Behnoush B Addict Sci Clin Pract. 2022; 17(1):68.

PMID: 36451181 PMC: 9709364. DOI: 10.1186/s13722-022-00349-8.


Is Methadone Safe for Patients With Opioid Use Disorder and Coronavirus Disease 2019 Infection?.

Owiti J, Benson M, Maplanka M, Oluseye L, Carvalho D J Addict Nurs. 2022; 33(2):86-94.

PMID: 35640212 PMC: 9186399. DOI: 10.1097/JAN.0000000000000457.


Antidepressant in the Treatment of Chronic Pain: A Case Report of Adult-Onset Still's Disease.

Jain A, Bodicherla K, Vanaparthy R Cureus. 2022; 13(12):e20180.

PMID: 35004004 PMC: 8723779. DOI: 10.7759/cureus.20180.


Psychotropics and COVID-19: An analysis of safety and prophylaxis.

Javelot H, Straczek C, Meyer G, Gitahy Falcao Faria C, Weiner L, Drapier D Encephale. 2021; 47(6):564-588.

PMID: 34548153 PMC: 8410507. DOI: 10.1016/j.encep.2021.08.002.